This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Albemarle's (ALB) Earnings & Sales Trounce Estimates in Q4
by Anindya Barman
Higher sales volumes and favorable pricing drove Albemarle's (ALB) results in Q4. The company provided an upbeat outlook for 2019.
Albemarle (ALB) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Albemarle (ALB) delivered earnings and revenue surprises of 4.79% and 3.57%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Can Albemarle (ALB) Maintain Earnings Beat Streak in Q4?
by Anindya Barman
Albemarle (ALB) will likely gain from higher expected volumes and pricing in its lithium business in Q4.
Albemarle (ALB) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Albemarle (ALB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Albemarle (ALB) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Albemarle (ALB) closed at $80.86 in the latest trading session, marking a -0.19% move from the prior day.
Albemarle Initiates Earthworks at Kemerton Lithium Site
by Zacks Equity Research
Albemarle's (ALB) site earthworks at Kemerton are on track and highlights commitment to develop LiOH operations in Western Australia.
US Chemical Industry Rebounds in November As Output Rises
by Anindya Barman
U.S. Chemical production went up across all regions in November barring the Gulf Coast.
Albemarle Enters Oversold Territory
by Zacks Equity Research
Albemarle Corpora has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
Albemarle & Mineral Resources Ink Deal to Form Lithium JV
by Zacks Equity Research
The JV formed by Albemarle (ALB) and Mineral Resources will own and operate the Wodgina project as well as produce spodumene concentrate and battery grade lithium hydroxide.
Albemarle (ALB) Well Placed on Lithium Expansion Actions
by Zacks Equity Research
Albemarle (ALB) to gain from strength in the lithium business and expansion actions.
Chemicals Start Q4 on Soft Note with Sluggish October Growth
by Anindya Barman
Global chemical production rose a paltry 0.1% in October following flat growth a month ago.
Why Is Albemarle (ALB) Down 13.9% Since Last Earnings Report?
by Zacks Equity Research
Albemarle (ALB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Should You Add Albemarle (ALB) Stock to Your Portfolio?
by Anindya Barman
Let's see why Albemarle (ALB) stock is worth buying right now.
Albemarle (ALB) Inks Exclusivity Deal with Mineral Resources
by Zacks Equity Research
Albemarle (ALB) has agreed to pay $1.15 billion for a 50% interest in the proposed JV.
Albemarle (ALB) Launches XPLORE & First Grade KF 787 PULSAR
by Zacks Equity Research
Albemarle (ALB) is committed to innovation in the market through KF 787 PULSAR and the XPLORE platform technology.
Albemarle (ALB) Q3 Earnings Top Estimates, Revenues Lag
by Anindya Barman
Higher lithium prices and gains across Bromine Specialties and Catalysts units drove Albemarle's (ALB) Q3 earnings.
Albemarle (ALB) Surpasses Q3 Earnings Estimates
by Zacks Equity Research
Albemarle (ALB) delivered earnings and revenue surprises of 4.80% and -3.31%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Can Albemarle (ALB) Beat Earnings in Q3 on Lithium Strength?
by Anindya Barman
Albemarle (ALB) is likely to gain from favorable pricing and volume trends in its Lithium segment in Q3.
Albemarle (ALB) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Albemarle (ALB) closed at $106.44, marking a +0.97% move from the previous day.
Albemarle (ALB) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Albemarle (ALB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Allegheny Technologies (ATI) Q3 Earnings: A Beat in Store?
by Zacks Equity Research
Allegheny's (ATI) FRP unit is likely to benefit from operational improvements and strong end-market demand.
Will Strong Demand Aid Cleveland-Cliffs' (CLF) Q3 Earnings?
by Zacks Equity Research
Cleveland-Cliffs' (CLF) Q3 results to benefit from strong demand for pellets.
Can Albemarle (ALB) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
Albemarle (ALB) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Is a Beat in the Cards for Celanese (CE) in Q3 Earnings?
by Zacks Equity Research
Celanese's (CE) strategic measures including cost savings through productivity actions and efficiency enhancement are expected to drive third-quarter earnings.
Will Higher Costs Dent PPG Industries' (PPG) Q3 Earnings?
by Anindya Barman
PPG Industries (PPG) faces cost pressure associated with raw materials and logistics that is likely to hurt its margins in Q3.